Clinical Trial Update: Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study [Phase 4]

View source ↗

Summary

A Phase 4 real-world safety and efficacy study of empagliflozin with or without metformin in type 2 diabetes mellitus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (Jardiance) (empagliflozin)
• metformin (Glucophage) (metformin)

Snippet

Sponsor: Getz Pharma | Conditions: Type II Diabetes Mellitus, Efficacy, Self | Phase 4 | Status: RECRUITING